EUVIMEDEUVIMED entdecken
Übersichtsarbeit

SOHO State of the Art Updates and Next Questions | Hyper-CVAD in 2022: Lessons Learned and New Approaches

Caitlin R Rausch, Hagop M Kantarjian, Elias J Jabbour

Clinical Lymphoma Myeloma and Leukemia · 2023-04 · 23 (4) · 238-243

DOI: 10.1016/j.clml.2023.01.013 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Clinical Lymphoma Myeloma and Leukemia, 2023-04. Verfasst von Caitlin R Rausch und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, TX. Hauptthemen laut MEDLINE: Doxorubicin, Precursor Cell Lymphoblastic Leukemia-Lymphoma. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DoxorubicinPrecursor Cell Lymphoblastic Leukemia-LymphomaAdultHumansCyclophosphamideRetrospective StudiesAntineoplastic Combined Chemotherapy ProtocolsDexamethasoneVincristine

Stichwörter der Autor:innen

ALLBlinatumomabHyper-CVADInotuzumabUpdate

Substanzen

DoxorubicinCyclophosphamideDexamethasoneVincristine

Autor:innen und Institutionen

  • Division of Pharmacy, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX.
  • Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX. Electronic address: ejabbour@mdanderson.org.

Zitieren

APA

Rausch, C. R., Kantarjian, H. M., & Jabbour, E. J. (2023). SOHO State of the Art Updates and Next Questions | Hyper-CVAD in 2022: Lessons Learned and New Approaches. Clinical Lymphoma Myeloma and Leukemia, 23(4), 238-243. https://doi.org/10.1016/j.clml.2023.01.013

Vancouver

Rausch CR, Kantarjian HM, Jabbour EJ. SOHO State of the Art Updates and Next Questions | Hyper-CVAD in 2022: Lessons Learned and New Approaches. Clinical Lymphoma Myeloma and Leukemia. 2023;23(4):238-243. doi:10.1016/j.clml.2023.01.013

BibTeX
@article{Rausch2023,
  author = {Rausch, Caitlin R and Kantarjian, Hagop M and Jabbour, Elias J},
  title = {SOHO State of the Art Updates and Next Questions | Hyper-CVAD in 2022: Lessons Learned and New Approaches},
  journal = {Clinical Lymphoma Myeloma and Leukemia},
  year = {2023},
  volume = {23},
  number = {4},
  pages = {238--243},
  doi = {10.1016/j.clml.2023.01.013}
}
Kostenlos starten →